Wall Street Zen upgraded shares of Nutex Health (NASDAQ:NUTX – Free Report) from a hold rating to a buy rating in a research note issued to investors on Saturday,Wall Street Zen reports.
A number of other research firms have also issued reports on NUTX. Weiss Ratings upgraded shares of Nutex Health from a “hold (c)” rating to a “hold (c+)” rating in a report on Tuesday, July 28th. Lake Street Capital restated a “buy” rating and issued a $310.00 price target (up from $235.00) on shares of Nutex Health in a research note on Tuesday, August 11th. Zacks Research upgraded Nutex Health from a “hold” rating to a “strong-buy” rating in a research note on Monday, August 24th. Finally, B. Riley Financial reiterated a “buy” rating on shares of Nutex Health in a report on Friday, September 4th. One equities research analyst has rated the stock with a Strong Buy rating, two have assigned a Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat.com, the stock has an average rating of “Buy” and a consensus target price of $317.50.
Check Out Our Latest Stock Report on NUTX
Nutex Health Price Performance
Nutex Health (NASDAQ:NUTX – Get Free Report) last released its earnings results on Thursday, August 6th. The company reported $9.38 earnings per share for the quarter, beating the consensus estimate of $4.95 by $4.43. The company had revenue of $210.75 million during the quarter, compared to the consensus estimate of $215.03 million. Nutex Health had a return on equity of 39.74% and a net margin of 21.25%. As a group, sell-side analysts expect that Nutex Health will post 27.58 earnings per share for the current year.
Insider Activity
In related news, Director Scott Saunders sold 203 shares of the business’s stock in a transaction dated Friday, September 18th. The stock was sold at an average price of $214.25, for a total value of $43,492.75. Following the transaction, the director owned 400 shares in the company, valued at $85,700. The trade was a 33.67% decrease in their position. The sale was disclosed in a legal filing with the SEC, which is available at the SEC website. 44.68% of the stock is currently owned by corporate insiders.
Hedge Funds Weigh In On Nutex Health
Several institutional investors have recently bought and sold shares of the company. Allworth Financial LP boosted its stake in shares of Nutex Health by 41.0% in the second quarter. Allworth Financial LP now owns 203 shares of the company’s stock valued at $35,000 after buying an additional 59 shares in the last quarter. Kilter Group LLC acquired a new stake in Nutex Health in the second quarter valued at $27,000. Islay Capital Management LLC acquired a new stake in Nutex Health in the fourth quarter valued at $34,000. Corient Private Wealth LP boosted its position in shares of Nutex Health by 5.1% during the 2nd quarter. Corient Private Wealth LP now owns 6,684 shares of the company’s stock worth $1,142,000 after purchasing an additional 325 shares in the last quarter. Finally, EverSource Wealth Advisors LLC purchased a new stake in shares of Nutex Health during the 1st quarter worth $83,000. 5.32% of the stock is owned by institutional investors and hedge funds.
About Nutex Health
Nutex Health Inc is a physician-led healthcare company that operates an integrated network of micro hospitals, specialty hospitals and other healthcare facilities. Its care-delivery business provides emergency, inpatient and outpatient services designed to offer localized access to hospital care, particularly in communities that may be underserved by traditional hospital systems.
The company also operates a population health management business. Through affiliated physician networks and independent physician associations, Nutex Health provides services such as care coordination, utilization management and support for value-based care arrangements.
Further Reading
- Five stocks we like better than Nutex Health
- NVIDIA’s Record High Raises a Bigger Question About How Far the Rally Can Run
- A Manufacturing Surprise Could Be a Big Win for These 2 Companies
- What a $1 Billion Chip Deal Says About Amazon’s AI Ambitions
- 3 Stocks Benefiting From AI Demand Just Announced Major Buybacks
Receive News & Ratings for Nutex Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Nutex Health and related companies with MarketBeat.com's FREE daily email newsletter.
